Feasibility of Opportunistic Bone Health Screening Using Chest X-rays

骨质疏松症是一种使人衰弱的疾病，会导致骨骼结构和密度的恶化，导致脆性骨折的风险显著增加。据估计，全球有17%的男性和34%的女性患有骨质疏松症，2017年，脆性骨折给英国造成了55亿欧元的损失，相关的一年死亡率为33%。该项目将评估进一步开发Trueview骨骼健康产品的可行性，使其可用于胸部x光检查，这占英国每年所有x光检查的28%。这将改善对骨骼健康不良的检测，使骨质疏松症能够更广泛和更早地识别和治疗。

Osteoporosis is a debilitating disease that leads to deterioration of bone structure and density, resulting in a significantly increased risk of fragility fractures. An estimated 17% of men and 34% of women are affected by osteoporosis worldwide and in 2017, fragility fractures cost the UK €5.5bn with an associated one-year mortality rate of 33%.This project will assess the feasibility of further developing the Trueview bone health product such that it can be used for chest X-rays, which account for 28% of all X-rays taken in the UK annually. This will improve the detection of poor bone health, enabling wider and earlier identification and treatment of osteoporosis.